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 The diagnostic yield of endomyocardial
biopsy is low, particularly in diseases that
affect the myocardium in a nonuniform
distribution.
 It is feasible to perform real-time
MRI-guided endomyocardial biopsy using
a dedicated active-visualization
bioptome.
 In an animal model of focal myocardial
disease, real-time MRI guidance improved
the diagnostic yield compared with x-ray
ﬂuoroscopy.Heart, Lung, and Blood Institute,
the cInstitute of Biomedical Engi-
h, National Heart, Lung, and Blood
Interventions Inc., which supplied
ips relevant to the contents of this
ent of Radiology and Radiological
13, 2016.
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377SUMMARY
AB BAND ACRONYM S
MRI = magnetic resonance
imagingDiagnostic yield of endomyocardial biopsy is low, particularly in disease that affects the myocardium in a
nonuniform distribution. The authors hypothesized that real-time MRI guidance could improve the yield
through targeted biopsy of focal myocardial pathology. They tested this hypothesis in an animal model of focal
myocardial pathology using intracoronary ethanol and microspheres. The authors compared real-time MRI-
guided endomyocardial biopsy in swine using a custom actively visualized MRI bioptome against x-ray–guided
biopsy using a commercial bioptome by skilled operators. Real-time MRI guidance signiﬁcantly increased the
diagnostic yield of endomyocardial biopsy. (J Am Coll Cardiol Basic Trans Science 2016;1:376–83) Published by
Elsevier on behalf of the American College of Cardiology Foundation. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).I n contemporary practice, endomyocardial biopsyis still performed with the limited visualguidance afforded by x-ray ﬂuoroscopy or by
ultrasound. Technique has changed little since its
inception in Japan in 1962 (1) and introduction to
the United States in 1973 (2). Regardless of the sus-
pected diagnosis, many operators perform only right
ventricular biopsy, and yet the diagnostic yield varies
dramatically depending on the distribution of disease
(3). Endomyocardial biopsy has fallen somewhat out
of favor in recent years, which in part may reﬂect
the low diagnostic yield in patients without trans-
planted hearts, and the complexity of cardiac histopa-
thology analysis (4). When positive, there is no
question that endomyocardial biopsy aids diagnosis
and directs therapy in patients with unexplained
heart failure (5). In skilled hands, procedural risk of
endomyocardial biopsy is low but complications
such as cardiac perforation can be life threatening
(6). Consequently, guidelines attempt to balance
these risks with the potential diagnostic beneﬁt. As
a result, the only “strong recommendation” for
endomyocardial biopsy in current guidelines is for
new-onset heart failure associated with hemody-
namic compromise or ventricular arrhythmias (7).SEE PAGE 384With better technology, it is conceivable that the
diagnostic yield of endomyocardial biopsy could be
signiﬁcantly improved. Developments in real-time
magnetic resonance imaging (MRI) pulse sequences
enable excellent tissue characterization and visuali-
zation of custom-built MRI-conditional devices, while
avoiding ionizing radiation (8). We hypothesized that
MRI guidance could augment the diagnostic yield of
endomyocardial biopsy of focal myocardial pathol-
ogy. To test this hypothesis, we created an animal
model of focal myocardial pathology and compared
the yield of x-ray–guided endomyocardial biopsy
using a commercial bioptome versus real-timeMRI-guided endomyocardial biopsy using a novel
MRI-conditional bioptome.
METHODS
The institutional animal care and use committee
approved all procedures, which were performed ac-
cording to contemporary National Institutes of Health
guidelines. Five Yorkshire swine with bodyweight
51 (47 to 56) kg were anesthetized with ketamine
(25 mg/kg), midazolam (15 mg/kg), and glycopyrrolate
(0.01 mg/kg), and maintained on isoﬂurane (2%) with
mechanical ventilation.
ANIMAL MODEL OF FOCAL MYOCARDIAL PATHOLOGY.
Animals were pre-treated with amiodarone and hep-
arin, and underwent x-ray–guided selective left cor-
onary artery catheterization from a transfemoral
approach using 6-F guide catheters. A $2-mm obtuse
marginal branch was wired with a 0.014-inch guide-
wire to position an over-the-wire balloon sized to
occlude ﬂow. Three milliliters of ﬂuorescent micro-
spheres (NuFlow Hydrocoat, 15-mm diameter,
5 million spheres/ml) was infused through the
balloon guidewire lumen, followed by 2 ml of 100%
ethanol to cause infarction within a controlled basal
posterolateral distribution. The ﬂuorescent micro-
spheres ensured that tissue within the lesion was
tagged for easy identiﬁcation under ultraviolet light.
There was no mortality from this procedure.
Animals were survived for 21 (14 to 22) days before
undergoing endomyocardial biopsy. Each animal
underwent both MRI and x-ray–guided endomyo-
cardial biopsy performed by different experienced
operators.
REAL-TIME MRI-GUIDED ENDOMYOCARDIAL BIOPSY.
MRI-guided endomyocardial biopsy was performed
in a MRI catheterization suite, equipped with a 1.5-T
standard diagnostic MRI scanner (Aera, Siemens,
Erlangen, Germany), noise-cancelling communication
headsets, and video projectors to display
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378hemodynamics and real-time MRI images at the
bedside (Figure 1) (9). The 6.5-F MRI-conditional bio-
ptome comprised hinged jaws fabricated from tita-
nium alloy in a copper-beryllium housingwith a Kevlar
actuation cable and a shapeable distal tip (MRI In-
terventions, Irvine, California) (Figure 2). The catheter
housing incorporated a dipole antenna and coaxial
cable. The device was visualized by a combination of
an active (“loopless”) dipole antenna receiver to
depict the distal 25-cm shaft and tip, and forceps ma-
terials that do not create a large MRI susceptibility
artifact. The bioptome included radiofrequency
chokes and decoupling circuitry to minimize heating
during MRI, and matching and tuning circuitry to
connect to the MRI scanner for active visualization
(Figure 3).
To aid visualization of the target infarcted
myocardium, 0.2 mmol/kg gadopentetate dimeglu-
mine (Bayer Healthcare, Wayne, New Jersey) was
administered intravenously. After 10 min, the lesion
was clearly visible using phase-sensitive inversion
recovery late gadolinium enhancement imaging
(Figure 4) (10). Under real-time MRI guidance, a 7-F
SL0, SL1, or SL2 sheath was introduced into the left
ventricle over a 0.035-inch nitinol guidewire (Nitrex,
Covidien, Minneapolis, Minnesota) via a transarterial
retrograde approach. The MRI bioptome was
advanced to the tip of the sheath and navigated to the
lesion using inversion recovery real-time imaging
(Figure 4). Typical imaging parameters were TI 417
ms, TR/TE 2.54/1.27 ms, ﬂip angle 45, ﬁeld of view
300 mm, slice thickness 6 mm, matrix 128  128,
GRAPPA factor 2, and frame rate 2 frames/s.
X-RAY FLUOROSCOPY–GUIDED ENDOMYOCARDIAL
BIOPSY. X-ray–guided endomyocardial biopsy was
performed using a single-plane x-ray ﬂuoroscopy sys-
tem (9). The operator was permitted to review the MRI
study, including the late gadolinium enhancement
images, before performing the biopsy. A commercial
7-F bioptome (Cordis, Fremont, California) was deliv-
ered to the left ventricle via transarterial retrograde
approach through a 7-F SL0, SL1, or SL2 sheath.
BIOPSY SPECIMEN ANALYSIS. Biopsy specimens
were examined using a Leica MZFIII dissecting mi-
croscope under transmitted light and ultraviolet light
with a 400- to 480-nm band pass ﬁlter. Each spec-
imen was classiﬁed as “on-target” if it contained $1
ﬂuorescent particles, or “miss” if it contained none.
STATISTICS. Data were analyzed using SPSS (version
19.0, IBM, Armonk, New York). Diagnostic yield is
presented as percentage of on-target specimens. All
other data are presented as median (ﬁrst and third
quartile). We tested the signiﬁcance of x-ray versusMRI biopsy using a Poisson regression model given
that multiple specimens were obtained from each
animal and therefore were not independent. A
p value <0.05 was considered signiﬁcant.
RESULTS
ANIMAL MODEL OF FOCAL MYOCARDIAL PATHOLOGY.
An endomyocardial lesion was successfully created
in all animals, without sustained ventricular
arrhythmia, hemodynamic compromise or mortality.
After 21 (14 to 22) days, the lesion was clearly
visible with late gadolinium enhancement imaging
(Figure 4). Left ventricular function was depressed
with ejection fraction 38% (34% to 42%).
Phase-sensitive inversion recovery and ex vivo MRI
conﬁrmed the lesion was transmural and focal
(Figure 2).
REAL-TIME MRI PROCEDURAL GUIDANCE. Retro-
grade left ventricular access was achieved easily in all
animals using real-time MRI guidance and a nitinol
guidewire. The active-visualization MRI-conditional
bioptome was clearly visible, and the bioptome jaws
were distinguishable from the shaft of the device by a
passive artifact (Figure 3, Video 1). Using the distal
10-cm shapeable tip of the bioptome and the angle of
the sheath tip, the bioptome was steered to the target
endocardial surface avoiding chordal entrapment
(Video 1). From each animal, 13 (10 to 20) biopsy
specimens were obtained under MRI guidance.
Fifteen (12 to 22) specimens were obtained under
x-ray guidance by a different skilled operator for
comparison.
ENDOMYOCARDIAL BIOPSY YIELD. A total of 87
specimens were obtained using x-ray guidance and 77
using real-time MRI guidance. Specimens obtained
with the 6.5-F MRI-conditional bioptome were
smaller compared with the commercial 7-F x-ray
bioptome (Figure 3). Specimens were classiﬁed as
on-target or miss depending on whether they con-
tained ﬂuorescent particles (Figure 3). Real-time MRI
guidance signiﬁcantly increased the diagnostic yield
of endomyocardial biopsy (63 of 77 [82%] vs. 49 of
87 [56%] on-target biopsy specimens with real-time
MRI vs. x-ray guidance, p < 0.001, odds ratio: 1.43
[95% conﬁdence interval: 1.19 to 1.74]) (Figure 5).
DISCUSSION
In this study, we demonstrate for the ﬁrst time, to our
knowledge, the feasibility of real-time MRI-guided
endomyocardial biopsy in vivo using an active visu-
alization MRI-conditional bioptome. In an animal
model of focal myocardial pathology, we demonstrate
FIGURE 1 Components of an Interventional MRI Suite
The operator wears a noise-cancelling headset for communication. Real-time magnetic
resonance images and hemodynamics are displayed in the room. MRI ¼ magnetic reso-
nance imaging.
FIGURE 2 Bioptome Design
Close up images of the jaws of conventional X-ray bioptome (Cordis) and the MRI-
conditional bioptome (MRI Interventions). MRI ¼ magnetic resonance imaging.
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379diagnostic superiority of MRI-guided biopsy in a
direct head-to-head comparison with the current
standard of care, x-ray ﬂuoroscopy–guided biopsy.
The excellent soft tissue visualization of MRI
is well suited to this application. Endomyocardial
biopsy is usually performed with x-ray ﬂuoroscopic
guidance. However, although x-ray enables clear
visualization of the bioptome, it cannot visualize the
myocardium. One strategy described in the literature
is to use electroanatomic mapping to identify
abnormal myocardium to biopsy (11). Although this
approach overcomes some of the limitations of x-ray–
guided biopsy, surface voltage mapping is not a reli-
able surrogate for pathological substrate in non-
ischemic cardiomyopathies (12), especially when
subendocardial. Pre-procedural MRI, with or without
late gadolinium enhancement, can inform the oper-
ator of the location and extent of pathology. Howev-
er, there is no way to conﬁrm that the bioptome is
delivered to the correct anatomic location until after
the specimens have been analyzed. By contrast, per-
forming the biopsy under direct real-time MRI guid-
ance ensures accurate targeting of the bioptome to
the pathology. In this experiment, we created a lesion
that was visible using late gadolinium enhancement
MRI. However, other MRI advanced tissue charac-
terization techniques such as T1 mapping or edema
imaging could be used in clinical practice to identify
abnormal myocardium for biopsy. These techniques
could in theory permit identiﬁcation of abnormal
myocardium without the need for systemic gadolin-
ium contrast administration. Clinical studies in pa-
tients with a variety of diagnoses are required to
conﬁrm the hypothesis that taking biopsy samples
from areas of late gadolinium enhancement or alter-
native pulse sequences for tissue characterization can
improve diagnostic yield.
The MRI-conditional bioptome we used required
considerable materials and electrical engineering for
device visualization and MRI safety. The nonferrous
forceps material needed to be MRI visible but not
create a large MRI susceptibility artifact that would
obscure nearby myocardium, and needed to be suf-
ﬁciently strong and sharp to obtain diagnostic speci-
mens. The catheter system was designed to serve
both mechanically as a bioptome and electrically as a
MRI receiver coil (13).
Repeat biopsies are often required to diagnose
diseases that affect the myocardial in a nonuniform
distribution (14). Targeted MRI-guided biopsy could
enable the operator to reduce the number of pro-
cedures and the number of specimens needed for
diagnosis. MRI-guided biopsy could also ensure
diagnostic yield with smaller volume specimens,allowing bioptome caliber to be reduced, especially
valuable for pediatric applications. Fewer and smaller
specimens could reduce the risk of myocardial
perforation from endomyocardial biopsy. Left ven-
tricular biopsy is often discouraged because the
FIGURE 3 Real-Time MRI-Guided Endomyocardial Biopsy
(A) Rapid frame-rate real-time magnetic resonance imaging (MRI) during navigation of the active visualization MRI bioptome within the left
ventricle to the target endocardial surface. The jaws appear as a passive artifact (arrow). (B) After systemic gadolinium contrast administration,
the lesion is visible using inversion-recovery real-time MRI (arrows). Real-time MRI-guided biopsy specimens viewed under (C) transmitted
light and (D) ultraviolet light. X-ray ﬂuoroscopy–guided biopsy specimens viewed under (E) transmitted light and (F) ultraviolet light. Also see
Video 1.
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380procedural risk may be higher than right ventricular
biopsy. However, the risk of cardiac perforation and
tamponade is probably higher with right ventricular
biopsy because the free wall is usually thin and moresusceptible to injury (3), and the cumulative risk of
biopsy-induced tricuspid valve injury is noteworthy
especially when applied to allograft surveillance (15).
Furthermore, the low risk of tamponade observed in
FIGURE 4 Magnetic Resonance Lesion Imaging
Phase-sensitive inversion recovery late gadolinium enhancement of lesion in (A) short axis and (B) long axis. Ex vivo high-resolution MRI of
myocardial lesion in (C) short axis and (D) long axis. Arrows denote lesion. MRI ¼ magnetic resonance imaging.
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381transplant patients undergoing biopsy may not
translate to patients with cardiomyopathy and a
naive pericardium. The pericardium is usually
adhered to the heart in transplant patients, which
may contain a right ventricular free wall perforation.
In processes that affect the heart diffusely, for
example inﬁltrative disease or transplant rejection,
right ventricle biopsy is usually sufﬁcient to reach
diagnosis. However, if pathology is focal and conﬁned
to the left ventricle, in particular myocarditis, then
the diagnostic yield of right ventricular biopsy will be
understandably low (16). Myocarditis can also affect
the epicardial surface preferentially. If this is the
case, then MRI guidance may not increase diagnosticyield of biopsy, whether taken from the left or right
ventricle. MRI guidance may offer the operator more
conﬁdence to perform left ventricular biopsy because
of the ability to visualize in real time how the bio-
ptome interacts with anatomic structures such as the
mitral valve apparatus, and rapidly identify compli-
cations such as pericardial perforation and tampo-
nade. Finally, MRI-guided biopsy avoids ionizing
radiation, which is of particular beneﬁt to pediatric
patients, but also to the operator and catheterization
laboratory personnel.
STUDY LIMITATIONS. The specimens obtained with
the 6.5-F MRI-conditional bioptome were smaller
than those obtained using the 7-F commercial x-ray
FIGURE 5 Diagnostic Yield of Real-Time MRI Versus X-Ray–Guided Endomyocardial Biopsy
Specimens were classiﬁed as on-target or miss by the presence or absence of ﬂuorescent
particles under ultraviolet light. MRI ¼ magnetic resonance imaging.
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE 1: The
diagnostic yield of endomyocardial biopsy is low in
disease processes that affect the myocardium in a
non-uniform distribution because it is difﬁcult to
selectively sample abnormal tissue using current
techniques.
COMPETENCY IN MEDICAL KNOWLEDGE 2:MRI
guidance can improve the diagnostic yield of endo-
myocardial biopsy by enabling real-time visualization
and targeting of abnormal myocardium with a novel
MRI-conditional bioptome.
TRANSLATIONAL OUTLOOK: The utility of MRI-
conditional myocardial bioptome should be tested in
adult and pediatric patients with myocarditis and after
heart transplantation.
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382bioptome, but did not affect the diagnostic yield in
this feasibility study. Different operators performed
MRI- and x-ray–guided biopsies, but the study was
not double blinded. Pre-procedural MRI could direct
the x-ray operator to the correct endocardial surface.
In order to minimize bias, the x-ray operator was
permitted to review the MRI study, including late
gadolinium enhancement images, beforehand. In this
early feasibility study, we did not test whether results
would vary for different regions of the left ventricle.
In 1 animal, the yield was low with both MRI and
x-ray guidance. On necropsy, it was apparent that the
lesion was “hidden” behind a papillary muscle.
Although it was clearly visible with real-time MRI, it
was difﬁcult to navigate the bioptome to the lesion.
The prototype MRI-conditional bioptome we tested
had a shapeable tip, but was not deﬂectable. Future
iterations of the MRI bioptome now in development
will incorporate an active deﬂection mechanism,
which should enable the operator to reach every part
of the endocardium, including the recesses behind
the papillary muscles. Steerable guiding catheters
could also improve the performance of x-ray
bioptomes.
We delivered the 7-F sheath to the left ventricle
using a commercially available nitinol guidewire.
Though nitinol guidewires are nonferromagnetic and
do not cause imaging artifacts, they are susceptible to
MRI radiofrequency-induced heating. For this reason,
nitinol guidewires cannot be used safely in humans atpresent. In the future, low-energy MRI pulse se-
quences may reduce radiofrequency-induced heating
sufﬁciently to enable safe use (17). Dedicated MRI-
conditional guidewires are currently under develop-
ment, incorporating either active or passive visuali-
zation technologies (18,19). The sheath we used is
intrinsically MRI safe because it does not contain
any metallic components. However, it was not MRI
conspicuous. A dedicated sheath with a passive MRI
marker at the tip would be useful for clinical
translation.
CONCLUSIONS
Targeted endomyocardial biopsy is feasible in a large
animal model using real-time MRI guidance.
Compared with conventional x-ray ﬂuoroscopy
guidance, MRI signiﬁcantly improves the diagnostic
yield despite smaller specimen volumes. MRI-guided
endomyocardial biopsy could be of particular value in
disease processes that affect the myocardium in a
nonuniform distribution.
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APPENDIX For supplemental videos and
their legends, please see the online version of
this article.
